Licks Attorneys - Media & Publications

Licks Attorneys

Após derrota com liminar no Brasil, Amazon diz que vai parar de usar tecnologia por trás de vídeo ultra HD e 4K no país



September 19, 2024

O Globo

2024

Ricardo Campello

Paula Carvalho

Eduardo Machado

O STJ e a publicidade de medicamentos



September 18, 2024

Jota

2024

Licks Attorneys

Licks Attorneys joins the 2024 AIPPI World Congress with a focus on Intellectual Property panels



September 17, 2024

The Legal 500

2024

Carolina Caetano

Gislaine Marks

O caso Via S/A e Magazine Luiza: uso de marcas em links patrocinados



September 11, 2024

Migalhas

2024

Ricardo Campello

Submissão de PDPs ao Ministério da Saúde termina dia 23



September 5, 2024

Valor Econômico

2024

Licks Attorneys

Challenges for the ANVISA (Brazilian FDA): Licks Attorneys provides analysis on the impact of new clinical trials legislation in Brazil



August 15, 2024

Regulatory Focus

2024

Eduardo Hallak

Ricardo Campello

Juliana Neves

Natália Toledo

Raíssa Gil

New PDP Regulation: Fresh Start or Same Old thing? - Part 1



August 12, 2024

Lexology

2024

Eduardo Hallak

Ricardo Campello

Juliana Neves

Natália Toledo

Raíssa Gil

Novidades do regulamento das PDPs são mesmo novidades? – Parte 1



August 12, 2024

Jota

2024

Juliana Neves

Gabriela Monteiro

Sarah Lucas

Intersecções entre propriedade intelectual e concorrência



August 8, 2024

Wia Podcast

2024

Ricardo Campello

Paula Carvalho

Does Law #14,874 address the obstacles that prevented Brazil from becoming a hub for clinical research?



August 6, 2024

Lexology

2024

Ricardo Campello

Paula Carvalho

Lei 14.874 resolve obstáculos que impediam Brasil de virar hub de pesquisa clínica?



August 6, 2024

Jota

2024

Ricardo Campello

Anna Secco

Beatriz Santos

Anvisa à beira do colapso



July 30, 2024

Jota

2024

Eduardo Hallak

Juliana Neves

Gabriela Monteiro

A brief overview of recent discussions and expected changes in the life sciences landscape for the upcoming future in Brazil



July 18, 2024

Leaders League

2024

Carolina Caetano

Arthur Ferreira

Lívia Costa

Marca RPM: precedente importante para disputas de marcas em regime de cotitularidade



July 13, 2024

Jota

2024

Licks Attorneys

Licks Attorneys analyzes the impact of Brazil's new clinical trials legislation



June 11, 2024

Regulatory Focus

2024

Otto Licks

The top Chinese patent holders adding Brazil to their strategic maps



June 4, 2024

IAM

2024

Carolina Caetano

PROPRIEDADES INTELECTUAIS N. 19/20 (JUN./NOV. 2023)



May 31, 2024

UCP Editora

2024

Juliana Neves

Networking in IP: the challenges and solutions for women



May 30, 2024

WIPR

2024

Ricardo Campello

Manda pro Jurídico



May 29, 2024

Manda pro Jurídico

2024

Ricardo Campello

O papel da Anvisa no futuro da Cannabis Medicinal no Brasil



May 24, 2024

Sechat

2024

Nuno Carvalho

The Intellectual Property of Food and Hospitality: From Sybaris’ Banquets to NASA’s Deep Space Food Program - A Sourcebook



May 9, 2024

Wolters Kluwer

2024

Regis Arslanian

Ricardo Campello

Natália Toledo

Camila Cardoso

Beatriz Santos

Electronic Smoking Devices (DEFs): Brazilian FDA upholds ban, now what?



April 24, 2024

Lexology

2024

Ricardo Campello

Gislaine Zulli

Natália Toledo

Anna Secco

Helena Almeida

Automatic cancellation of Cannabis Products’ authorizations by Anvisa: incentive or setback?



April 24, 2024

Lexology

2024

Ricardo Campello

Gislaine Zulli

Natália Toledo

Anna Secco

Helena Almeida

Cancelamento automático dos produtos de cannabis pela Anvisa



April 24, 2024

Jota

2024



No results found.

Please try different filters.

Media & publications

Após derrota com liminar no Brasil, Amazon diz que vai parar de usar tecnologia por trás de vídeo ultra HD e 4K no país

O STJ e a publicidade de medicamentos

Licks Attorneys joins the 2024 AIPPI World Congress with a focus on Intellectual Property panels

O caso Via S/A e Magazine Luiza: uso de marcas em links patrocinados

Submissão de PDPs ao Ministério da Saúde termina dia 23

Challenges for the ANVISA (Brazilian FDA): Licks Attorneys provides analysis on the impact of new clinical trials legislation in Brazil

New PDP Regulation: Fresh Start or Same Old thing? - Part 1

Novidades do regulamento das PDPs são mesmo novidades? – Parte 1

Intersecções entre propriedade intelectual e concorrência

Does Law #14,874 address the obstacles that prevented Brazil from becoming a hub for clinical research?

Lei 14.874 resolve obstáculos que impediam Brasil de virar hub de pesquisa clínica?

Anvisa à beira do colapso

A brief overview of recent discussions and expected changes in the life sciences landscape for the upcoming future in Brazil

Marca RPM: precedente importante para disputas de marcas em regime de cotitularidade

Licks Attorneys analyzes the impact of Brazil's new clinical trials legislation

The top Chinese patent holders adding Brazil to their strategic maps

PROPRIEDADES INTELECTUAIS N. 19/20 (JUN./NOV. 2023)

Networking in IP: the challenges and solutions for women

Manda pro Jurídico

O papel da Anvisa no futuro da Cannabis Medicinal no Brasil

The Intellectual Property of Food and Hospitality: From Sybaris’ Banquets to NASA’s Deep Space Food Program - A Sourcebook

Electronic Smoking Devices (DEFs): Brazilian FDA upholds ban, now what?

Automatic cancellation of Cannabis Products’ authorizations by Anvisa: incentive or setback?

Cancelamento automático dos produtos de cannabis pela Anvisa

事務所

リオデジャネイロ

サンパウロ

ブラジリア

クリチバ

東京

新型コロナウィルス感染症安全対策認証事務所